Clinical utility of biomarkers of systemic inflammation for patients with metastatic renal cell carcinoma.

e15617 Background: The presence or absence of systemic inflammation has been associated with dramatic changes in prognosis for patients with metastatic renal cell carcinoma (mRCC). In this study we...